Fusion event
HBV-chr19 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
ATACTGCGGAACTCCTAGCCGCTTGTTTTGCTCGCAGCAGGTCTGGAGCAAACATTATCGGGACTGATAACTCTGTTGTCCTATCCCGCAAATATACATC| |GTTTCCATGGCTGCTAGGCTGTGCTGCCAACTGGATCCTGCGCGGGACGTCCTTTGTTTACGTCCCGTCGGCGCTGAATCCTGCGGACGACCCTTCTCGG
End
28859205/28368298 (Hg38)
Nearest miRNA
hsa-mir-10395/Upstream/7968944; hsa-let-7e/Downstream/6754402;
Upstream sequence
ctttcttctttcttctctttctctctttctttctttcATTAtttttttttgacagagtcttgctctgtccaccaggctggagtgtgtgatcatggcttac
Downstream sequence
tgcagcctcaacctcctcatctcaagcaattctcccatctcagtctcctgagtagctgagactacaggcatgagccaccatgctcggttgattttttatc
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.